Sofie Lundgren, MD1,2*, Timo Järvinen1,2,3*, Mikko A Keränen, MD, PhD1,2,4*, Jason Theodoropoulos, BSc1,2*, Daehong Kim, PhD1,2*, Urpu Salmenniemi, MD5,6*, Gunilla Walldin7*, Paula Savola, MD, PhD1,2,8*, Tiina Kelkka, PhD1,2*, Hanna Rajala, MD, PhD1,2,4*, Pekka Ellonen, BSc9*, Eva Hellström-Lindberg, MD, PhD7, Maija Itälä-Remes, MD, PhD5*, Mikko Myllymäki, MD, PhD1,2*, Matti Kankainen, PhD1,2,3* and Satu Mustjoki, MD, PhD1,2,10
1Translational Immunology Research program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland
2Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
3Medical and Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
4Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
5Stem Cell Transplantation Unit, Turku University Hospital, Turku, Finland
6Stem Cell Transplantation Unit, HUCH Comprehensive Cancer Center, Helsinki, Finland, Helsinki, Finland
7Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden
8Clinical Chemistry, HUS Diagnostic Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
9HILIFE, Institute for Molecular Medicine Finland (FIMM), Helsinki, Finland
10iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland